Table 2.
Performance of qPitt, qSOFA and SOFA for 30-day mortality in patients with community-acquired urinary tract infection
| AUROC (IC 95%) | Sensitivity (IC 95%) | Specificity (IC 95%) | Positive predictive value (IC 95%) | Negative predictive value (IC 95%) | |
|---|---|---|---|---|---|
| qPitt ≥ 2 | 0.692 (0.605–0.779) | 70.45 (55.84–85.07) | 60.36 (54.99–65.72) | 18.79 (12.52–25.05) | 94.01 (90.62–97.40) |
| qSOFA ≥ 2 | 0.832 (0.761–0.903) | 84.09 (72.15–96.03) | 82.25 (78.03–86.47) | 38.14 (27.96–48.33) | 97.54 (95.57–99.52) |
| SOFA ≥ 2 | 0.806 (0.731–0.881) | 84.09 (72.15–96.03) | 63.61 (58.33–68.89) | 23.13 (16.28–29.97) | 96.85 (94.32–99.37) |
| p qPitt vs. qSOFA | 0.010 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
| p qPitt vs. SOFA | 0.041 | < 0.001 | 0.742 | 0.085 | < 0.001 |